Last reviewed · How we verify
NCT04211727
Affinity: Hospital Trial
trial testing Capillary finger prick blood sample in Cancer in 247 participants. Completed in 17 January 2022.
17 January 2022
Quick facts
| Lead sponsor | Entia Ltd |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 247 |
| Start date | 26 October 2020 |
| Primary completion | 17 January 2022 |
| Estimated completion | 17 January 2022 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Capillary finger prick blood sample
Conditions studied
- Cancer — all drugs for Cancer →
Sponsor
Entia Ltd
Who can join
18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Method comparison study to compare the Affinity prototype device using a capillary blood sample against routine venous laboratory results, in patients undergoing systemic anti-cancer therapy (SACT). Tests will be performed by healthcare professionals (Cohort 1) and participants self-testing (Cohort 2)
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04211727
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other Entia Ltd trials
Trials by the same sponsor.
- NCT07031882 — Liberty Analyzer WBC System: Reference Interval Study · not yet recruiting
- NCT06544070 — Capillary Blood Accuracy · not yet recruiting
- NCT06134245 — HOme USability Evaluation · unknown
- NCT05926362 — Capillary-Venous Paired Data Collection · not yet recruiting
- NCT05462288 — Entia Liberty: Home Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04211727 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Entia Ltd
- Last refreshed: 29 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04211727.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing